Hillstream BioPharma, Inc.

Hillstream BioPharma, Inc.verified

HILS

Price:

$0.237

Market Cap:

$4.17M

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar IC50 against PI3K-delta and HDAC6, which is also known to downregulate; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor ...[Read more]

Industry

Biotechnology

IPO Date

2022-01-12

Stock Exchange

NASDAQ

Ticker

HILS

The ROE as of December 2024 (TTM) for Hillstream BioPharma, Inc. (HILS) is -172.28%

According to Hillstream BioPharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -172.28%. This represents a change of -97.63% compared to the average of -7263.96% of the last 4 quarters.

Hillstream BioPharma, Inc. (HILS) Historical ROE (quarterly & annually)

How has HILS ROE performed in the past?

The mean historical ROE of Hillstream BioPharma, Inc. over the last ten years is -10.80%. The current -172.28% ROE has changed 1.50% with respect to the historical average. Over the past ten years (40 quarters), HILS's ROE was at its highest in in the December 2020 quarter at 34.86%. The ROE was at its lowest in in the December 2022 quarter at -28792.75%.

Quarterly (TTM)
Annual

Average

-10.80%

Median

63.88%

Minimum

-152.84%

Maximum

72.19%

Hillstream BioPharma, Inc. (HILS) ROE by Quarter and Year

Discovering the peaks and valleys of Hillstream BioPharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.51%

Maximum Annual ROE = 72.19%

Minimum Annual Increase = -335.71%

Minimum Annual ROE = -152.84%

Quarterly (TTM)
Annual
YearROEChange
2023-102.06%-33.23%
2022-152.84%-335.71%
202164.84%1.51%
202063.88%-11.52%

Hillstream BioPharma, Inc. (HILS) Average ROE

How has HILS ROE performed in the past?

The current ROE of Hillstream BioPharma, Inc. (HILS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-63.35%

5-year avg

-10.80%

10-year avg

-10.80%

Hillstream BioPharma, Inc. (HILS) ROE vs. Peers

How is HILS’s ROE compared to its peers?

Hillstream BioPharma, Inc.’s ROE is less than Virax Biolabs Group Limited (0%), greater than Blue Water Vaccines, Inc. (-115.10%), greater than Revelation Biosciences, Inc. (-151.78%), greater than Kiora Pharmaceuticals, Inc. (-311.33%), less than ZyVersa Therapeutics, Inc. (21.31%), greater than Palisade Bio, Inc. (-25512.50%), greater than Unicycive Therapeutics, Inc. (-148.31%), greater than Apexigen, Inc. (-374.14%), less than Immix Biopharma, Inc. (48.27%), greater than Quoin Pharmaceuticals, Ltd. (-102.10%), greater than PaxMedica, Inc. Common Stock (-126.19%), greater than Cardio Diagnostics Holdings, Inc. (-3167.06%), greater than null (-258.81%),

Build a custom stock screener for Hillstream BioPharma, Inc. (HILS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hillstream BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hillstream BioPharma, Inc. (HILS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hillstream BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Hillstream BioPharma, Inc.'s ROE?

How is the ROE calculated for Hillstream BioPharma, Inc. (HILS)?

What is the highest ROE for Hillstream BioPharma, Inc. (HILS)?

What is the 3-year average ROE for Hillstream BioPharma, Inc. (HILS)?

What is the 5-year average ROE for Hillstream BioPharma, Inc. (HILS)?

How does the current ROE for Hillstream BioPharma, Inc. (HILS) compare to its historical average?